Study on the Correlation Between Interleukin-27 and CXCL10 in Pulmonary Tuberculosis

Overview

Journal J Immunol Res

Publisher Wiley

Specialty Allergy & Immunology

Date 2022 Jul 5

PMID 35785034

Authors

Jiahui Fan

Yefeng Yang

Liang Wang

Xiaoqian Shang

Li Zhang

Hu Sun

Yujie Ma

Ying Li

Jing Wang

Xiumin Ma

Affiliations

Soon will be listed here.

Abstract

Objective: To investigate the correlation between interleukin-27 and CXCL10 and other cytokines in pulmonary tuberculosis and to further explore the related miRNAs through bioinformatics.

Methods: Collect the lesion tissue and peripheral blood of pulmonary tuberculosis patients and the peripheral blood of healthy controls. Immunohistochemical staining and qRT-PCR were used to observe the expression of interleukin-27, CXCL9, CXCL10, and CXCL11. Then, predict the key miRNA, qRT-PCR was used to verify the expression of miRNA in the peripheral blood and evaluated the correlation between them.

Results: Both immunohistochemical staining and qRT-PCR indicated that the expressions of IL-27, CXCL9, CXCL10, and CXCL11 were significantly increased in tuberculosis patients, and IL-27 was significantly correlated with CXCL10 ( = 0.68). Key molecules such as has-let-7b-5p, has-miR-30a-3p, and has-miR-320b were screened out. Among them, has-let-7b-5p was significantly downregulated, and has-miR-30a-3p was significantly upregulated; they were related to interleukin-27 and CXCL10.

Conclusion: Our data shows that interleukin-27 and CXCL10 are significantly related in pulmonary tuberculosis, and has-let-7b-5p and has-miR-30a-3p are also related to interleukin-27 and CXCL10. It laid the foundation for subsequently exploiting the potential biomarkers in tuberculosis disease.

Citing Articles

IL-27 attenuated macrophage injury and inflammation induced by Mycobacterium tuberculosis by activating autophagy.

Zhou Y, Zhang Y, Li Y, Liu L, Zhuang M, Xiao Y In Vitro Cell Dev Biol Anim. 2024; 61(2):245-256.

PMID: 39455490 DOI: 10.1007/s11626-024-00989-x.

Transcriptomics-based anti-tuberculous mechanism of traditional Chinese polyherbal preparation NiuBeiXiaoHe intermediates.

Wang N, Ma Q, Zhang J, Wang J, Li X, Liang Y Front Pharmacol. 2024; 15:1415951.

PMID: 39364045 PMC: 11446850. DOI: 10.3389/fphar.2024.1415951.

Plasma chemokines CXCL10 and CXCL9 as potential diagnostic markers of drug-sensitive and drug-resistant tuberculosis.

Sampath P, Rajamanickam A, Thiruvengadam K, Natarajan A, Hissar S, Dhanapal M Sci Rep. 2023; 13(1):7404.

PMID: 37149713 PMC: 10163852. DOI: 10.1038/s41598-023-34530-z.

References

Basset L, Chevalier S, Danger Y, Arshad M, Piquet-Pellorce C, Gascan H . Interleukin-27 and IFNγ regulate the expression of CXCL9, CXCL10, and CXCL11 in hepatitis. J Mol Med (Berl). 2015; 93(12):1355-67. DOI: 10.1007/s00109-015-1319-6. View

Xu Q, Cheng D, Li G, Liu Y, Li P, Sun W . CircHIPK3 regulates pulmonary fibrosis by facilitating glycolysis in miR-30a-3p/FOXK2-dependent manner. Int J Biol Sci. 2021; 17(9):2294-2307. PMC: 8241722. DOI: 10.7150/ijbs.57915. View

Chung W, Jung Y, Lee K, Park J, Sheen S, Park K . CXCR3 ligands in pleural fluid as markers for the diagnosis of tuberculous pleural effusion. Int J Tuberc Lung Dis. 2018; 21(12):1300-1306. DOI: 10.5588/ijtld.17.0232. View

Sun H, Fan J, Shang X, Tuohetaerbaike B, Li Y, Lv J . Study on the relationship between CXCR3 and its ligands and tubal tuberculosis. Life Sci. 2021; 272:119047. DOI: 10.1016/j.lfs.2021.119047. View

Lee K, Chung W, Jung Y, Kim Y, Park J, Sheen S . CXCR3 ligands as clinical markers for pulmonary tuberculosis. Int J Tuberc Lung Dis. 2015; 19(2):191-9. DOI: 10.5588/ijtld.14.0525. View

Reimand J, Isserlin R, Voisin V, Kucera M, Tannus-Lopes C, Rostamianfar A . Pathway enrichment analysis and visualization of omics data using g:Profiler, GSEA, Cytoscape and EnrichmentMap. Nat Protoc. 2019; 14(2):482-517. PMC: 6607905. DOI: 10.1038/s41596-018-0103-9. View

Blauenfeldt T, Petrone L, Del Nonno F, Baiocchini A, Falasca L, Chiacchio T . Interplay of DDP4 and IP-10 as a Potential Mechanism for Cell Recruitment to Tuberculosis Lesions. Front Immunol. 2018; 9:1456. PMC: 6041415. DOI: 10.3389/fimmu.2018.01456. View

Harding E . WHO global progress report on tuberculosis elimination. Lancet Respir Med. 2019; 8(1):19. DOI: 10.1016/S2213-2600(19)30418-7. View

Shi L, Jiang Q, Bushkin Y, Subbian S, Tyagi S . Biphasic Dynamics of Macrophage Immunometabolism during Infection. mBio. 2019; 10(2). PMC: 6437057. DOI: 10.1128/mBio.02550-18. View

10.

Yu H, Liu J, Zhang Z, Zhu Y, Bi J, Kong C . SNHG12 promotes carcinogenesis of human renal cell cancer via functioning as a competing endogenous RNA and sponging miR-30a-3p. J Cell Mol Med. 2021; 25(10):4696-4708. PMC: 8107103. DOI: 10.1111/jcmm.16417. View

11.

Akino Mercy C, Muthukumaran N, Velusamy P, Bothammal P, Sumaiya K, Saranya P . MicroRNAs Regulated by the LPS/TLR2 Immune Axis as Bona Fide Biomarkers for Diagnosis of Acute Leptospirosis. mSphere. 2020; 5(4). PMC: 7364213. DOI: 10.1128/mSphere.00409-20. View

12.

Szklarczyk D, Morris J, Cook H, Kuhn M, Wyder S, Simonovic M . The STRING database in 2017: quality-controlled protein-protein association networks, made broadly accessible. Nucleic Acids Res. 2016; 45(D1):D362-D368. PMC: 5210637. DOI: 10.1093/nar/gkw937. View

13.

Chitnis A, Jaganath D, Gish R, Wong R . Diagnosis and Treatment of Latent Tuberculosis Infection. Am J Gastroenterol. 2021; 116(11):2155-2158. DOI: 10.14309/ajg.0000000000001398. View

14.

Abdalla A, Li Q, Xie L, Xie J . Biology of IL-27 and its role in the host immunity against Mycobacterium tuberculosis. Int J Biol Sci. 2015; 11(2):168-75. PMC: 4279092. DOI: 10.7150/ijbs.10464. View

15.

Heikkila O, Nygardas M, Paavilainen H, Ryodi E, Hukkanen V . Interleukin-27 Inhibits Herpes Simplex Virus Type 1 Infection by Activating STAT1 and 3, Interleukin-6, and Chemokines IP-10 and MIG. J Interferon Cytokine Res. 2016; 36(11):617-629. DOI: 10.1089/jir.2016.0015. View

16.

Zhang M, Li D, Hu Z, Huang Y . The diagnostic utility of pleural markers for tuberculosis pleural effusion. Ann Transl Med. 2020; 8(9):607. PMC: 7290547. DOI: 10.21037/atm.2019.09.110. View

17.

Valdez-Miramontes C, Trejo Martinez L, Torres-Juarez F, Rodriguez Carlos A, Marin-Luevano S, de Haro-Acosta J . Nicotine modulates molecules of the innate immune response in epithelial cells and macrophages during infection with M. tuberculosis. Clin Exp Immunol. 2019; 199(2):230-243. PMC: 6954679. DOI: 10.1111/cei.13388. View

18.

Kumar N, Hissar S, Thiruvengadam K, Banurekha V, Balaji S, Elilarasi S . Plasma chemokines as immune biomarkers for diagnosis of pediatric tuberculosis. BMC Infect Dis. 2021; 21(1):1055. PMC: 8504024. DOI: 10.1186/s12879-021-06749-6. View

19.

Hosokawa Y, Hosokawa I, Ozaki K, Matsuo T . Honokiol and Magnolol Inhibit CXCL10 and CXCL11 Production in IL-27-Stimulated Human Oral Epithelial Cells. Inflammation. 2018; 41(6):2110-2115. DOI: 10.1007/s10753-018-0854-z. View

20.

Gan Y, Guo S, Zhu Y, Jiang J, Tan Y . Exogenous intrapleural injection of interleukin-27 may improves outcome and prognosis in patients with tuberculous pleural effusion. Med Hypotheses. 2019; 131:109319. DOI: 10.1016/j.mehy.2019.109319. View